Zusammenfassung
Die hohe Inzidenz und langsame Wachstumsgeschwindigkeit (Proliferationsrate 6%) mit einer Verdopplungszeit von über 100 Tagen beeinflussen die Nachsorge von Patienten mit einem Prostatakarzinom. Eine programmierte Nachsorge wird der biologischen Besonderheit des Prostatakarzinoms nur bedingt gerecht, wenngleich ein derartiges Vorgehen in der urologischen Praxis die Zuverlässigkeit der Patientenführung erhöht. Die Nachsorge muß eine Progression des Primärtumors ebenso wie den Relaps nach kurativer Behandlung aufdecken, den das Auftreten von Lymphknoten und Knochenmetastasen kennzeichnet (Tabelle 1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Altwein JE, Jocham D, Schrott KM, Wirth M, Hölzel D (1989) Empfehlungen zur Tumornachsorge (Prostata). Bayer Ärztebl 44: 10
Bagshaw MA (1980) External radiation therapy of carcinoma of the prostate. Cancer 45: 1912
Berry WR, Laszlo J, Cox E, Walker A, Paulson D (1979) Prognostic factors in metastatic and hormonally unresponsive carcinoma of the prostate. Cancer 44: 763
Bishop MC, Ansell ID, Taylor MC, Thomas AL (1985) Serial prostatic histology. A valid marker of response to hormone treatment. Br J Urol 57: 453
Chodak GW, Vogelzang NJ, Caplan RJ et al. (1991) Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. J Am Med Assoc 265: 618
DeVoogt HJ, Suciun S, Sylvester R et al. (1989) Multivariate analysis of prostatic cancer: Results from 2 EORTC-trials. J Urol 141: 883
Gittes RF (1991) Carcinoma of the prostate. N Engl J Med 324: 236
Grundmann E (1988) Neue Möglichkeiten der Krebsnachsorge. Dtsch Ärztebl 85: 959
Hölzel D, Sauer H, Waal JC (1988) Tumornachsorge-Schemata: Wissensinhalt — Anwendung — Optimierung. Onkologie 11: 202
Hovsepian JA, Byar DP (1975) VACURG-studies of Carcinoma of prostate. Correlation between radiologic quantitation of métastases and patient survival. Urology 6: 11
Kabalin JN, Hodge KK, McNeal JE et al. (1989) Identification of residual cancer in the prostate following radiation therapy: role of transrectal ultrasound guided biopsy and prostate specific antigen. J Urol 142: 326
Killian GS, Yang N, Emrich LJ et al. (1985) Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. Cancer Res 45: 886
Koutsilieris M, Tolis G (1985) Long-term follow-up of patients with advanced prostatic carcinoma treated with either buserelin or orchiectomy: Classification of variables associated with disease outcome. Prostate 7: 31
Leitenberger A, Schneider W, Altwein JE (1991) Do serial PSA determinations offer the best insight into treatment behavior of advanced prostatic cancer? A pilot study of 130 patients. J Urol 145: 384A
Merrick MV, Ding CL, Chisholm GG, Elton RA (1985) Prognostic significance of alkaline and acid phosphatase and skeletal scintigraphy in carcinoma of the prostate. Br J Urol 57: 795
Oesteriing JE, Chan DW, Epstein JI et al. (1988) Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766
Paulson DF (1988) Diagnosis of metastatic or locally recurrent prostate cancer. In: McCullough DL (ed) Difficult Diagnosis in Urology. Churchill Livingstone, New York, p277
Smith PH, Armitage TG, Cooper EH (1990) Deferred treatment in localized prostatic cancer. Prog Clin Biol Res 359: 191
Sommerkamp H, Altwein JE (1989) Lokale Tumorkontrolle — Effizienz kurativer Verfahren. In: Sommerkamp H, Altwein JE (Hrsg) Prostatakarzinom — Spektrum der kurativen Therapie. Karger, Basel, S 322
Stamey TA, Kabalin JN, Ferrari M (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients. J Urol 141: 1084
Whitmore WF (1973) The natural history of prostatic cancer. Cancer 32: 1104
Wilson DW, Harper ME, Jensen RM, Ikeda RM, Richards G, Peeling WB, Pierrepoint CG, Griffiths K (1985) A prognostic index for the clinical management of patients with advanced prostatic cancer. Prostate 7: 131
Zincke H (1989) Salvage-Chirurgie bei lokalem Therapieversagen nach Strahlentherapie. In: Sommerkamp H, Altwein JE (Hrsg) Prostatakarzinom — Spektrum der kurativen Therapie. Karger, Basel, S 287
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Altwein, J.E. (1991). Nachsorge von Patienten mit Prostatakarzinom (mit einem Abriβ über prognostische Faktoren). In: Ackermann, R., Altwein, J.E., Faul, P. (eds) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84264-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-84264-1_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84265-8
Online ISBN: 978-3-642-84264-1
eBook Packages: Springer Book Archive